AI-generated analysis. Always verify with the original filing.
Telix Pharmaceuticals Limited filed a Form 6-K on February 18, 2026. The filing reports Items as N/A with no specific disclosure content provided.
Event Type
Disclosure
Voluntary
Variant
6-K
Current Report on Form 6-K